South Korea's Pharma-Biotech Companies to Invest US$9.31 Billion

Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info is tracking 430 active pharmaceutical and biotech projects in South Korea with a total investment value of US$9.31 billion. The projects include new site construction, plant expansions, maintenance, etc. Lotte Biologics (Seoul, South Korea) currently accounts for the largest investment amount. Lotte has confirmed three plant expansion projects, totaling approximately US$3 billion worth of investment. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical-Biotech Project Database can learn more by viewing the related project reports.

Industrial Info Resources (IIR) is the leading provider of industrial market intelligence. Since 1983, IIR has provided comprehensive research, news and analysis on the industrial process, manufacturing and energy related industries. IIR's Global Market Intelligence (GMI) helps companies identify and pursue trends across multiple markets with access to real, qualified and validated plant and project opportunities. Across the world, IIR is tracking over 200,000 current and future projects worth $17.8 trillion (USD).